- Current report filing (8-K)
May 04 2009 - 2:17PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported):
April 30,
2009
|
(Exact
name of registrant as specified in its charter)
|
|
|
|
|
|
|
(State
or other jurisdiction
of
incorporation)
|
(Commission
File
Number)
|
(IRS
Employer
Identification
No.)
|
|
|
|
Kells
Building, 621 Shady Retreat Road, P.O. Box 1349, Doylestown,
PA
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code:
xxx
|
(Former
name or former address, if changed since last
report.)
|
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions (
see
General
Instruction A.2. below):
¨
Written communications
pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material
pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
¨
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
Item
8.01 Other
Events.
On April 30, 2009, Quigley Pharma Inc.,
a wholly-owned subsidiary of The Quigley Corporation, issued a press release
announcing that their recently completed Phase 2 double-blinded,
placebo-controlled, clinical trial of diabetic peripheral neuropathy,
demonstrated a significant improvement in two key measures of distal sensory
nerve function in the group treated with their QR333 drug. The full text
of the press release is attached hereto as Exhibit 99.1.
Item
9.01 Financial
Statements and Exhibits.
(d) Exhibits.
|
Exhibit
No.
|
Description
|
|
99.1
|
Press
Release issued on April 30,
2009
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
|
THE
QUIGLEY CORPORATION
|
|
|
(Registrant)
|
|
|
|
|
Date:
May 4, 2009
|
|
|
|
|
|
By:
|
/s/
Gerard
M. Gleeson
|
|
|
Name:
|
Gerard
M. Gleeson
|
|
|
Title:
|
Vice
President and Chief Financial
Officer
|
INDEX
TO EXHIBITS
Exhibit
99.1 Press
Release issued on April 30, 2009
The Quigley (MM) (NASDAQ:QGLY)
Historical Stock Chart
From Sep 2024 to Oct 2024
The Quigley (MM) (NASDAQ:QGLY)
Historical Stock Chart
From Oct 2023 to Oct 2024